A multi-institutional research team has demonstrated how artificial intelligence and machine learning can optimize therapy selection and dosing for septic shock, a life-threatening complication that ...

SYDNEY--(BUSINESS WIRE)--Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announced an international patent application aimed at protecting the use of experimental ...

Inotrem and Roche’s diagnostics division have upgraded their years-long collaboration on a plasma test for septic shock, with a new worldwide licensing agreement. The France-based Inotrem secured the ...

Sepsis is the body’s extreme reaction to an infection. It causes 11 million deaths annually and is a global health priority affecting 55 million patients worldwide annually. Treatment for sepsis ...

Leukopenia may be seen in sepsis as one of the systemic inflammatory response syndrome (SIRS) criteria, ie, white blood cell count below 4000, and may portend a poor prognosis. But severe leukopenia, ...

Cirrhosis, malignancy, and acute kidney injury are among the clinical factors associated with early mortality in patients with septic shock.

PARIS--(BUSINESS WIRE)--Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and chronic inflammatory syndromes, disclosed for the first time today at the ...

Subgroup analysis showed that 2 biomarkers, ADM and cDPP3, could help identify patients who would benefit most from enibarcimab therapy. The Food and Drug Administration (FDA) has granted Fast Track ...

The NQF issued this statement when reached for comment Tuesday: "NQF's Patient Safety Measures Standing Committee is empanelled and will conduct an ad hoc review of this measure as a result of this ...

For patients with septic shock, treatment with intravenous vitamin C, hydrocortisone, and thiamine did not significantly improve the duration of survival and free of vasopressor administration over 7 ...